文献速递血液净化与透析慢性肾脏病

透析机构视角下Medicare Advantage扩张的财务影响

Dialysis Organization Perspectives on the Financial Repercussions of the Expansion of Medicare Advantage.
PubMed 文献 · Clin J Am Soc Nephrol · 2026-07-22

本研究通过半结构化深度访谈,探讨Medicare Advantage(MA)扩张对透析机构的财务与组织影响。访谈37名来自6家透析机构的行政与临床人员,识别出合同谈判差异、患者自付费用负担及对小机构财务可持续性的担忧三个主题。结论认为MA扩张对大、小透析机构造成不均衡财务后果,需持续监测以确保不损害透析服务可及性与质量。

要点

  • 大型透析机构在MA合同谈判中获得更有利的费率和利润率。
  • MA自付上限虽节省患者费用,但达到上限前的支出仍构成显著负担。
  • 小透析机构吸收坏账,担忧财务可持续性与市场整合。

核心结论

  • MA扩张对大和小透析机构产生不均衡的财务后果,引发对整合、可持续性和照护质量的担忧。
  • 需要持续监测以确保MA快速增长不损害透析机构的财务稳定性或患者照护的可及性与质量。

研究设计与样本

  • 描述性质性研究,采用改良扎根理论和内容分析法分析访谈转录。
  • 招募两家大型全国性和四家小型区域性透析机构的行政领导与临床人员,于2022年1月至2024年5月进行半结构化深度访谈。
  • 共访谈来自六家透析机构的37名行政领导与临床人员。

主要发现

  • 与MA计划的合同谈判被描述为复杂,大型透析机构获得比小机构更有利的费率和利润率。
  • MA自付上限对肾衰竭患者具有成本节约作用,但达到上限前的费用被描述为患者的显著财务负担,常导致医疗债务,小机构报告将其作为坏账吸收。
  • 透析机构对MA扩张的长期财务影响表示担忧,指出高医疗保健成本、患者MA参保趋势以及小机构在市场整合中的财务不稳定性。

临床怎么用

  • 肾内科医生应关注肾衰竭患者在MA计划下的自付费用负担,包括达到自付上限前的支出。
  • 临床团队需了解透析机构规模差异对MA合同费率及财务可持续性的影响,以协助患者导航保险与照护选择。

局限性

  • 本研究为描述性质性研究,基于六家透析机构的37名人员访谈,结果可能不适用于其他机构或地区。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

KEY POINTS: Negotiated contracts with Medicare Advantage resulted in differing reimbursement rates and profit margins depending on the size of the dialysis organization. Small dialysis organizations reported absorbing bad debt and expressed concern about financial sustainability and market consolidation. Dialysis organizations described kidney-related medical care costs as substantial even with Medicare Advantage cost-sharing strategies. BACKGROUND: Following the 2021 policy change that opened Medicare Advantage (MA) enrollment to all Medicare beneficiaries with kidney failure, MA enrollment among this population has risen sharply. However, little is known about the financial and organizational consequences of this expansion for dialysis providers. METHODS: Administrative leadership and clinical staff from two large national and four small regional dialysis organizations were recruited to participate in semistructured, in-depth interviews. Interviews were conducted with executive, financial, and clinical staff from January 2022 to May 2024. This descriptive qualitative study analyzed interview transcripts using a modified grounded theory and content analysis approach. RESULTS: Interviews were conducted with 37 administrative leadership and clinical staff from six dialysis organizations. Three main themes were identified reflecting their experiences managing the fiscal repercussions of MA expansion: ( 1 ) contract negotiations with MA plans were described as complicated, with large dialysis organizations securing more favorable rates and profit margins than small dialysis organizations; ( 2 ) although MA out-of-pocket caps were cost-saving for patients with kidney failure, the expenses before reaching maximums were described by dialysis leadership and staff as a significant financial burden for their patients, often leading to medical debt-a cost that small dialysis organizations reported absorbing as bad debt; and ( 3 ) dialysis organizations expressed concerns around the long-term financial impacts of MA expansion noting high health care costs, MA enrollment trends by their patients with kidney failure, and financial instability amid market consolidation for small dialysis providers. CONCLUSIONS: MA expansion created uneven financial consequences for large and small dialysis organizations, raising concerns about consolidation, sustainability, and care quality. Ongoing monitoring is needed to ensure that the rapid growth of MA does not compromise the financial stability of dialysis providers or access and quality of care for patients with kidney failure.

来源:Clin J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Brazier JF, Tyler DA, Shah AD, et al. Dialysis Organization Perspectives on the Financial Repercussions of the Expansion of Medicare Advantage. Clin J Am Soc Nephrol. 2026. PMID: 42485098. doi:10.2215/CJN.0000001161

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。